Intermittent fasting is often promoted as a method for losing weight and improving metabolic health. GLP-1 receptor agonists such as semaglutide or liraglutide are also used specifically for weight loss. So the obvious question is: can both approaches be combined – or is that too much of a good thing?
Why prolonged intermittent fasting is not recommended during GLP-1 therapy
With GLP-1 treatment, the appetite is greatly reduced anyway. If this is combined with long fasting intervals such as 16/8 or 5:2, the risk of insufficient energy and nutrient intake increases. The consequences can be
- Increased side effects such as nausea, bloating or circulatory problems because the stomach is emptied even more slowly.
- Insufficient energy and nutrient intake, which can lead to muscle atrophy and persistent fatigue.
- yo-yo effect after stopping the injection, as a strong calorie deficit lowers the basal metabolic rate in the long term.
Regular meals – sometimes even a little more frequently throughout the day than usual – help to avoid these risks. They stabilize blood sugar, facilitate digestion and ensure a balanced supply of energy and nutrients.
What still makes sense: 12 hours of night fasting
A nightly fast of around 12 hours (e.g. dinner at 7 pm, breakfast at 7 am) is recommended as a healthy basis – even during GLP-1 therapy. Studies show that even such a moderate time window:
- can improve insulin sensitivity
- Lowers inflammation markers
- and supports metabolic flexibility.
This level of intermittent fasting is suitable for everyday use, safe and brings benefits without the risks of longer periods of fasting.
Conclusion: balance instead of extremes
While classic forms of intermittent fasting are not recommended in combination with GLP-1, a 12-hour overnight fast can certainly have positive effects. However, it is crucial to eat regularly and in a balanced way during the eating window:
- Sufficient protein for muscle maintenance
- Complex carbohydrates for energy
- healthy fats and fiber for satiety
- Micronutrients for metabolic health
In this way, the effect of GLP-1 can be optimally supported without unnecessarily stressing the body or driving it into a deficiency.
Sources
- Patterson RE, Sears DD. Metabolic Effects of Intermittent Fasting. Annu Rev Nutr. 2017;37:371-393. PubMed
- Meier JJ, et al. Glucagon-like peptide 1 (GLP-1) infusion in healthy men during prolonged fasting does not cause reactive hypoglycemia. J Clin Endocrinol Metab. 2009;94(2): 618-25. PubMed
- Lundgren JR, et al. Healthy weight loss maintenance with exercise, liraglutide, or both combined. Diabetologia. 2021;64:1775–1786. SpringerLink